Table 2.
Six-gene-based classification of samples based on histology compared to age, size, capsule invasion degree, vascular invasion foci, cytological diagnosis (Bethesda system) and genotype.
Sample ID | Histology | Age (years) | Size (mm) | Capsule invasion degree | Vascular invasion foci | Bethesda category | Genotype | Prediction | Probability (%) |
---|---|---|---|---|---|---|---|---|---|
FA1 | FA | 41 | 35 | None | None | III | WT | FA | 76 |
FA13 | FA | 58 | 28 | None | None | III | WT | FA | 65 |
FA14 | FA | 19 | 18 | None | None | IV | WT | FA | 65 |
FA2 | FA | 55 | 25 | None | None | III | WT | FA | 82 |
FA25 | FA | 35 | 34 | None | None | III | WT | FA | 75 |
FA26 | FA | 34 | 18 | None | None | IV | WT | MI-FTC | 51 |
FA3 | FA | 31 | 44 | None | None | IV | WT | FA | 78 |
FA39 | FA | 50 | 20 | None | None | III | WT | FA | 54 |
FA40 | FA | 47 | 50 | None | None | III | WT | FA | 91 |
FA41 | FA | 51 | 15 | None | None | III | WT | FA | 63 |
FA42 | FA | 53 | 10 | None | None | NA | WT | FA | 90 |
FA70 | FA | 40 | 26 | None | None | III | WT | FA | 79 |
FA80 | FA | 41 | 30 | None | None | III | WT | FA | 90 |
FA81 | FA | 45 | 36 | None | None | III | WT | MI-FTC | 88 |
FA82 | FA | 49 | 25 | None | None | NA | WT | FA | 58 |
FA83 | FA | 50 | 42 | None | None | III | WT | FA | 81 |
FA85 | FA | 40 | 28 | None | None | III | WT | FA | 80 |
FA91 | FA | 35 | 52 | None | None | NA | WT | FA | 100 |
MI-FTC19 | MI-FTC | 45 | 15 | Entire | <4 | III | WT | MI-FTC | 80 |
MI-FTC22 | MI-FTC | 64 | 26 | Entire | <4 | III | NRAS Q61K | WI-FTC | 75 |
NRAS M72L | |||||||||
TERT C228T | |||||||||
MI-FTC30 | MI-FTC | 34 | 22 | Partial | None | IV | WT | MI-FTC | 91 |
MI-FTC33 | MI-FTC | 59 | 22 | Partial | <4 | III | WT | MI-FTC | 58 |
MI-FTC36 | MI-FTC | 63 | 34 | Partial | <4 | NA | PAX8-PPARG ex. 7 | MI-FTC | 62 |
MI-FTC50 | MI-FTC | 45 | 50 | Entire | None | III | WT | MI-FTC | 67 |
MI-FTC51 | MI-FTC | 69 | 28 | Partial | None | III | WT | MI-FTC | 92 |
MI-FTC58 | MI-FTC | 55 | 22 | Partial | None | IV | WT | MI-FTC | 73 |
MI-FTC59 | MI-FTC | 28 | 18 | Entire | <4 | IV | WT | MI-FTC | 83 |
MI-FTC60 | MI-FTC | 42 | 10 | Partial | <4 | NA | WT | FA | 56 |
MI-FTC61 | MI-FTC | 39 | 18 | Entire | None | NA | WT | MI-FTC | 84 |
MI-FTC92 | MI-FTC | 41 | 22 | Entire | None | III | WT | MI-FTC | 74 |
MI-FTC93 | MI-FTC | 38 | 35 | Entire | None | NA | WT | FA | 63 |
MI-FTC94 | MI-FTC | 72 | 22 | Partial | <4 | III | KRAS Q61R | WI-FTC | 93 |
TERT C228T | |||||||||
WI-FTC4 | WI-FTC | 63 | 38 | Entire | >4 | III | WT | WI-FTC | 70 |
WI-FTC48 | WI-FTC | 29 | 15 | Entire | <4 | III | NRAS Q61R | WI-FTC | 100 |
WI-FTC49 | WI-FTC | 63 | 60 | Entire | >4 | IV | WT | FA | 72 |
WI-FTC5 | WI-FTC | 53 | NA | Entire | >4 | NA | NRAS Q61R | WI-FTC | 100 |
WI-FTC69 | WI-FTC | 77 | NA | Entire | >4 | V | NRAS Q61R | WI-FTC | 100 |
WI-FTC75 | WI-FTC | 73 | 57 | Entire | >4 | IV | NRAS Q61R | WI-FTC | 95 |
Probability refers to the reliability of classification according to the distance from histological class centroids.
FA, follicular adenoma; MI-FTC, minimally invasive follicular thyroid carcinoma; NA, not available; WI-FTC, widely invasive follicular thyroid carcinoma.